160 related articles for article (PubMed ID: 25070103)
1. Efficacy of PTX3 and posaconazole combination in a rat model of invasive pulmonary aspergillosis.
Marra E; Sousa VL; Gaziano R; Pacello ML; Arseni B; Aurisicchio L; De Santis R; Salvatori G
Antimicrob Agents Chemother; 2014 Oct; 58(10):6284-6. PubMed ID: 25070103
[TBL] [Abstract][Full Text] [Related]
2. Posaconazole-Loaded Leukocytes as a Novel Treatment Strategy Targeting Invasive Pulmonary Aspergillosis.
Baistrocchi SR; Lee MJ; Lehoux M; Ralph B; Snarr BD; Robitaille R; Sheppard DC
J Infect Dis; 2017 Jun; 215(11):1734-1741. PubMed ID: 27799353
[TBL] [Abstract][Full Text] [Related]
3. Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals.
Gaziano R; Bozza S; Bellocchio S; Perruccio K; Montagnoli C; Pitzurra L; Salvatori G; De Santis R; Carminati P; Mantovani A; Romani L
Antimicrob Agents Chemother; 2004 Nov; 48(11):4414-21. PubMed ID: 15504871
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics of Posaconazole in Experimental Invasive Pulmonary Aspergillosis: Utility of Serum Galactomannan as a Dynamic Endpoint of Antifungal Efficacy.
Gastine S; Hope W; Hempel G; Petraitiene R; Petraitis V; Mickiene D; Bacher J; Walsh TJ; Groll AH
Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33168606
[No Abstract] [Full Text] [Related]
5. Efficacy of PTX3 in a rat model of invasive aspergillosis.
Lo Giudice P; Campo S; Verdoliva A; Rivieccio V; Borsini F; De Santis R; Salvatori G
Antimicrob Agents Chemother; 2010 Oct; 54(10):4513-5. PubMed ID: 20625145
[TBL] [Abstract][Full Text] [Related]
6. Blood and tissue distribution of posaconazole in a rat model of invasive pulmonary aspergillosis.
Cendejas-Bueno E; Forastiero A; Ruiz I; Mellado E; Gavaldà J; Gomez-Lopez A
Diagn Microbiol Infect Dis; 2017 Feb; 87(2):112-117. PubMed ID: 27889253
[TBL] [Abstract][Full Text] [Related]
7. Posaconazole pharmacodynamic target determination against wild-type and Cyp51 mutant isolates of Aspergillus fumigatus in an in vivo model of invasive pulmonary aspergillosis.
Lepak AJ; Marchillo K; Vanhecker J; Andes DR
Antimicrob Agents Chemother; 2013 Jan; 57(1):579-85. PubMed ID: 23147740
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis.
Lewis RE; Albert ND; Kontoyiannis DP
Antimicrob Agents Chemother; 2014 Nov; 58(11):6767-72. PubMed ID: 25182639
[TBL] [Abstract][Full Text] [Related]
9. Effect of PTX3 and voriconazole combination in a rat model of invasive pulmonary aspergillosis.
Lo Giudice P; Campo S; De Santis R; Salvatori G
Antimicrob Agents Chemother; 2012 Dec; 56(12):6400-2. PubMed ID: 23006752
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of posaconazole for invasive pulmonary aspergillosis: clinical implications for antifungal therapy.
Howard SJ; Lestner JM; Sharp A; Gregson L; Goodwin J; Slater J; Majithiya JB; Warn PA; Hope WW
J Infect Dis; 2011 May; 203(9):1324-32. PubMed ID: 21357943
[TBL] [Abstract][Full Text] [Related]
11. Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial.
Maertens JA; Rahav G; Lee DG; Ponce-de-León A; Ramírez Sánchez IC; Klimko N; Sonet A; Haider S; Diego Vélez J; Raad I; Koh LP; Karthaus M; Zhou J; Ben-Ami R; Motyl MR; Han S; Grandhi A; Waskin H;
Lancet; 2021 Feb; 397(10273):499-509. PubMed ID: 33549194
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.
Karthaus M
Eur J Med Res; 2011 Apr; 16(4):145-52. PubMed ID: 21486728
[TBL] [Abstract][Full Text] [Related]
13. Intrapulmonary posaconazole penetration at the infection site in an immunosuppressed murine model of invasive pulmonary aspergillosis receiving oral prophylactic regimens.
Seyedmousavi S; Brüggemann RJ; Melchers WJ; Verweij PE; Mouton JW
Antimicrob Agents Chemother; 2014 May; 58(5):2964-7. PubMed ID: 24566183
[TBL] [Abstract][Full Text] [Related]
14. Posaconazole prophylaxis in experimental azole-resistant invasive pulmonary aspergillosis.
Seyedmousavi S; Mouton JW; Melchers WJ; Verweij PE
Antimicrob Agents Chemother; 2015 Mar; 59(3):1487-94. PubMed ID: 25534731
[TBL] [Abstract][Full Text] [Related]
15. Pentraxin 3 Gene Polymorphisms and Pulmonary Aspergillosis in Chronic Obstructive Pulmonary Disease Patients.
He Q; Li H; Rui Y; Liu L; He B; Shi Y; Su X
Clin Infect Dis; 2018 Jan; 66(2):261-267. PubMed ID: 29020397
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of anidulafungin combined with posaconazole in experimental aspergillosis.
Martin-Vicente A; Capilla J; Guarro J
Med Mycol; 2017 Jun; 55(4):457-460. PubMed ID: 27760829
[TBL] [Abstract][Full Text] [Related]
17. A case report of intravenous posaconazole in hepatic and renal impairment patient with invasive Aspergillus terreus infection: safety and role of therapeutic drug monitoring.
Dilokpattanamongkol P; Panusitthikorn P; Boonprasert R; Chayakulkeeree M; Rotjanapan P
BMC Pharmacol Toxicol; 2017 Jan; 18(1):8. PubMed ID: 28143591
[TBL] [Abstract][Full Text] [Related]
18. Interaction between posaconazole and flucloxacillin in a lung transplant patient: decrease in plasma exposure of posaconazole and possible undertreatment of invasive aspergillosis: case report.
Verfaillie S; Godinas L; Spriet I; Vos R; Verleden GM
BMC Pulm Med; 2022 Mar; 22(1):110. PubMed ID: 35346142
[TBL] [Abstract][Full Text] [Related]
19. Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis.
McCulloch E; Ramage G; Rajendran R; Lappin DF; Jones B; Warn P; Shrief R; Kirkpatrick WR; Patterson TF; Williams C
J Clin Pathol; 2012 Jan; 65(1):83-6. PubMed ID: 22049217
[TBL] [Abstract][Full Text] [Related]
20. Our 2015 approach to invasive pulmonary aspergillosis.
Liss B; Vehreschild JJ; Bangard C; Maintz D; Frank K; Grönke S; Michels G; Hamprecht A; Wisplinghoff H; Markiefka B; Hekmat K; Vehreschild MJ; Cornely OA
Mycoses; 2015 Jun; 58(6):375-82. PubMed ID: 25808916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
